This whole session was v high yield IMO

👏Amer. Urol. Assn. #aua24

Thanks UroToday.com & Rashid K. Sayyid for the great coverage!

International Prostate Forum was an awesome mix of knowledge from all over the world

👏John W. Davis, MD MD Anderson Cancer Center

Amer. Urol. Assn. #aua24

Great talk by Anael Rizzo showing #race does not predict receipt of secondary treatment for #bcr in our VA SEARCH #prostatecancer database. Matt Cooperberg Zach Klaassen Lourdes Guerrios MD,MSc

👏Jim Hu preventing updated results of PREVENT 2 TP Vs TR prostate biopsy

Starting to see a signal for 📉infection w/ TP

🚫Zero infx w/ TP & no antibx (n=372)
🦠6 infx w/ TR & targeted antibx (n=370)

Weill Cornell Medicine Urology Amer. Urol. Assn. #Aua24 NM Urology

This was an incredible talk by Michael Liss. Amazing data on microbiome and association with prostate cancer detection. Maybe even modifiable 🤯 #AUA24

👏Thank you Freddie Hamdy for asking the tough questions on focal therapy for #Prostatecancer

✴️“We should drive the technology and not let the technology drive us.”

Amer. Urol. Assn. #aua24 Prostate Cancer Foundation PCF Science International Prostate Forum UroToday.com Urology Times

#AUA24 Amer. Urol. Assn. #MedStudent #MedEd Forum happening at #AUA24 . Very high yield info for #MedStudent s interested in applying to #Urology . #MedStudent s can join Amer. Urol. Assn. for free, w/access to great resources. Excellent panel discussion moderated by Marisa Clifton.…

Interested to learn about the best practices in TURBT and En bloc resection of bladder tumour? Join our instructional course on Monday 6th May 7:30am at Room 214A! #AUA24 #ERBT

Register here: aua2021.app.swapcard.com/event/2024-ann…

Integrating both clinicopathologic ( STARCAP) and genomic risk (Decipher by Veracyte) classifiers will be 🔑 for personalizing care for our #ProstateCancer pts

#aua24

Udit Singhal, MD 👏

Mayo Clinic Urology Michigan Urology Amer. Urol. Assn. Prostate Cancer Foundation PCF Science MUSIC Urology Todd 〽️ Morgan, MD

1) love this group
2) love that we completely blocked the #aua24 signage

We want to give a HUGE shoutout to our Who to Follow list for doing such a great job covering the meeting! Keep following them and #AUA24 for more amazing content! Adam B. Weiner, MD Steve Nakada Kevin Koo Corinna Hughes Angie Smith Khurshid Ghani Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺 Justin Dubin, MD…

Ongoing Society of Urologic Oncology debate #AUA24

🤖 robot v 🔪 open rplnd for #testicularcancer

Scott Eggener debunks the myth of unique recurrence patterns after the robotic approach
Amer. Urol. Assn. YUO UChicago Urology

So thankful for this ⭐️ team! Emily Ji Aurash N. Tavakolian, MD Diboro Kanabolo Rebe Arteaga NM Urology

A full house at the Lila Cockrell Theater during today’s Society of Urologic Oncology programming kickoff as Leslie Ballas shares the future of radiation therapy for localized and oligometastatic #RCC #AUA24 #WUO Amer. Urol. Assn.

Insights on the history of black urologists taking place in the S&T Hall

👏Happy to see this content prioritized in #aua24

Amer. Urol. Assn. R. Frank Jones Urological Society

Who’s ready for #aua24 day 2??

Amer. Urol. Assn.

How are docs communicating life expectancy (LE) to patients w/ PCa? John R. Heard, MD, MS Timothy Daskivich study suggests

➡️Significant heterogeneity in communication style

➡️ Non-evidence based calculations of LE

Improvements needed in calculation/communication to avoid over-treatment

EMBARK: Survival outcomes of patients who d/c therapy by 37 weeks
🔷Enza +LHRHa: 90.4% d/c therapy
🔷LHRHa: 67%
🔷Enza mono: 85.6%

Re-started therapy for PSA rise following d/c
🔷Enza +LHRHa: 75%
🔷LHRHa: 84%
🔷Enza mono: 89%

Re-achieve an undetectable PSA response
🔷Enza…

Head on over to plenary session to catch UCLA Urology chair give the Lattimer lecture on precision oncology #aua24

Amer. Urol. Assn.

.Phillip Pierorazio is dropping some knowledge on navigating a big conference like #aua24 in case you’ve missed them Amer. Urol. Assn.